HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adinolfi, L. E. Articles by Bonventre, P. F. Search for Related Content PubMed PubMed Citation Articles by Adinolfi, L. E. Articles by Bonventre, P. F.

Enhancement of Glucantime® Therapy of Murine Leishmania Donovani Infection by a Synthetic Immunopotentiating Compound (CP-46,665-1)

The therapeutic efficacy of CP-46,665-1, a synthetic lipoidal amine with proven immunomodulatory and anti-tumor properties, in combination with chemotherapy was evaluated in L. donovani-infected C57Bl/6 mice. Immunostimulation and drug treatment resulted in a 10-fold lesser infection level than in untreated mice, while animals treated with Glucantime® alone exhibited only a modest amelioration of the infection. We also studied the capacity of CP-elicited peritoneal macrophages of C57Bl/6 mice cultured alone or in combination with Glucantime® and/or lymphokine to eliminate intracellular L. donovani amastigotes. When CP-elicited cells were incubated with Glucantime®, they exhibited a significantly higher killing potential than did drug treated thioglycollate-elicited cells. CP-macrophages stimulated with lymphokine alone or in combination with antimonial drug, killed amastigotes more rapidly and efficiently than similarly treated thioglycollate-elicited macrophages. In vivo and in vitro results of this study show that a combined regimen of immunostimulation with CP and antimonial drug is more effective in treatment of L. donovani infection than either treatment alone.

Accepted for publication October 2, 1984.

^* Permanent address: Clinica Malattie Tropicali e Subtropicali, I^a Facolta' di Medicina e Chirurgia, Universita' di Napoli, Via Cotugno, 1, 80135 Napoli, Italia.

This article has been cited by other articles:

				P. A. Barroso, J. D. Marco, M. Calvopina, H. Kato, M. Korenaga, and Y. Hashiguchi A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate J. Antimicrob. Chemother., June 1, 2007; 59(6): 1123 - 1129. [Abstract] [Full Text] [PDF]